» Articles » PMID: 32470982

A Chronic Fetal Leucine Infusion Potentiates Fetal Insulin Secretion and Increases Pancreatic Islet Size, Vascularity, and β Cells in Late-Gestation Sheep

Overview
Journal J Nutr
Publisher Elsevier
Date 2020 May 30
PMID 32470982
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Infusion of a complete amino acid mixture into normal late-gestation fetal sheep potentiates glucose-stimulated insulin secretion (GSIS). Leucine acutely stimulates insulin secretion in late-gestation fetal sheep and isolated fetal sheep islets in vitro.

Objectives: We hypothesized that a 9-d leucine infusion would potentiate GSIS in fetal sheep.

Methods: Columbia-Rambouillet fetal sheep at 126 days of gestation received a 9-d leucine infusion to achieve a 50%-100% increase in leucine concentrations or a control infusion. At the end of the infusion we measured GSIS, pancreatic morphology, and expression of pancreatic mRNAs. Pancreatic islet endothelial cells (ECs) were isolated from fetal sheep and incubated with supplemental leucine or vascular endothelial growth factor A (VEGFA) followed by collection of mRNA. Data measured at multiple time points were compared with a repeated-measures 2-factor ANOVA. Data measured at 1 time point were compared using Student's t test or the Mann-Whitney test.

Results: Glucose-stimulated insulin concentrations were 80% higher in leucine-infused (LEU) fetuses than in controls (P < 0.05). In the pancreas, LEU fetuses had a higher proportion of islets >5000 μm2 than controls (75% more islets >5000 μm2; P < 0.05) and a larger proportion of the pancreas that stained for β cells (12% greater; P < 0.05). Pancreatic and pancreatic islet vascularity were both 25% greater in LEU fetuses (P < 0.05). Pancreatic VEGFA and hepatocyte growth factor (HGF) mRNA expressions were 38% and 200% greater in LEU fetuses than in controls (P < 0.05), respectively. In isolated islet ECs, HGF mRNA was 20% and 50% higher after incubation in supplemental leucine (P < 0.05) or VEGFA (P < 0.01), respectively.

Conclusions: A 9-d leucine infusion potentiates fetal GSIS, demonstrating that glucose and leucine act synergistically to stimulate insulin secretion in fetal sheep. A greater proportion of the pancreas being comprised of β cells and higher pancreatic vascularity contributed to the higher GSIS.

Citing Articles

IGF-1 LR3 does not promote growth in late-gestation growth-restricted fetal sheep.

White A, Stremming J, Wesolowski S, Al-Juboori S, Dobrinskikh E, Limesand S Am J Physiol Endocrinol Metab. 2024; 328(1):E116-E125.

PMID: 39679943 PMC: 11901354. DOI: 10.1152/ajpendo.00259.2024.


Chronic late gestation fetal hyperglucagonaemia results in lower insulin secretion, pancreatic mass, islet area and beta- and α-cell proliferation.

Cilvik S, Boehmer B, Wesolowski S, Brown L, Rozance P J Physiol. 2024; 602(22):6329-6345.

PMID: 39383208 PMC: 11576258. DOI: 10.1113/JP286974.


Pulsatile Leucine Administration during Continuous Enteral Feeding Enhances Skeletal Muscle Mechanistic Target of Rapamycin Complex 1 Signaling and Protein Synthesis in a Preterm Piglet Model.

Rudar M, Suryawan A, Nguyen H, Chacko S, Vonderohe C, Stoll B J Nutr. 2023; 154(2):505-515.

PMID: 38141773 PMC: 10900192. DOI: 10.1016/j.tjnut.2023.12.034.


RISING STARS: Mechanistic insights into maternal-fetal cross talk and islet beta-cell development.

Jo S, Alejandro E J Endocrinol. 2023; 259(3).

PMID: 37855321 PMC: 10692651. DOI: 10.1530/JOE-23-0069.


Attenuated glucose-stimulated insulin secretion during an acute IGF-1 LR3 infusion into fetal sheep does not persist in isolated islets.

White A, Stremming J, Brown L, Rozance P J Dev Orig Health Dis. 2023; 14(3):353-361.

PMID: 37114757 PMC: 10205682. DOI: 10.1017/S2040174423000090.


References
1.
Dai C, Huh C, Thorgeirsson S, Liu Y . Beta-cell-specific ablation of the hepatocyte growth factor receptor results in reduced islet size, impaired insulin secretion, and glucose intolerance. Am J Pathol. 2005; 167(2):429-36. PMC: 1603568. DOI: 10.1016/s0002-9440(10)62987-2. View

2.
Garcia-Ocana A, Vasavada R, Cebrian A, Reddy V, Takane K, Lopez-Talavera J . Transgenic overexpression of hepatocyte growth factor in the beta-cell markedly improves islet function and islet transplant outcomes in mice. Diabetes. 2001; 50(12):2752-62. DOI: 10.2337/diabetes.50.12.2752. View

3.
Fowden A . Effects of adrenaline and amino acids on the release of insulin in the sheep fetus. J Endocrinol. 1980; 87(1):113-21. DOI: 10.1677/joe.0.0870113. View

4.
Malaisse W, Sener A, Herchuelz A, Hutton J . Insulin release: the fuel hypothesis. Metabolism. 1979; 28(4):373-86. DOI: 10.1016/0026-0495(79)90111-2. View

5.
Sener A, Malaisse W . L-leucine and a nonmetabolized analogue activate pancreatic islet glutamate dehydrogenase. Nature. 1980; 288(5787):187-9. DOI: 10.1038/288187a0. View